Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia.
[read the full story...]Should people with schizophrenia be offered depot antipsychotics as first line treatment?
Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.
[read the full story...]Long-acting injectable paliperidone palmitate for schizophrenia
Tracey Roberts summarises a recent RCT of the efficacy and safety of paliperidone palmitate 3-month formulation for patients with schizophrenia.
[read the full story...]